Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.

Citation data:

Clinical lymphoma, myeloma & leukemia, ISSN: 2152-2669, Vol: 17, Issue: 4, Page: 193-200

Publication Year:
2017
Usage 39
Abstract Views 38
Link-outs 1
Captures 8
Exports-Saves 8
Citations 2
Citation Indexes 2
PMID:
28209473
DOI:
10.1016/j.clml.2016.10.001
Author(s):
Hsi, Eric D, Horwitz, Steven M, Carson, Kenneth R, Pinter-Brown, Lauren C, Rosen, Steven T, Pro, Barbara, Federico, Massimo, Gisselbrecht, Christian, Schwartz, Marc, Bellm, Lisa A, Acosta, Mark, Collie, Angela M, Gruver, Aaron M, Grzywacz, Bartosz J, Turakhia, Samir, Shustov, Andrei R, Advani, Ranjana H, Feldman, Tatyana, Lechowicz, Mary Jo, Smith, Sonali M, Lansigan, Frederick, Tulpule, Anil, Craig, Michael D, Greer, John P, Kahl, Brad S, Leach, Joseph W, Morganstein, Neil, Casulo, Carla, Park, Steven I, Foss, Francine M Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine, Biochemistry, Genetics and Molecular Biology
article description
With increased understanding of the unique entities, subtype-specific approaches for peripheral T-cell lymphoma (PTCL) are emerging, and more precise diagnoses are becoming increasingly important. PATIENTSĀ AND METHODS: We analyzed the approach to the histopathologic diagnosis of PTCL using data from the comprehensive oncology measures of peripheral T-cell lymphoma (COMPLETE) study. The COMPLETE trial is a large prospective cohort study of patients with newly diagnosed PTCL in the United States.

This article has 0 Wikipedia mention.